📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lifecare

1.1 - Company Overview

Lifecare Logo

Lifecare

Headquarter: Norway
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of miniaturized, implantable glucose sensors and nano biosensing solutions. Offerings include Sencell, a real-time glucose sensor measuring osmotic pressure, lasting at least six months and transmitting data wirelessly to smart devices; NanoBioSensors for high-resolution diagnostics in live tissue; and Lifecare Veterinary for continuous animal glucose monitoring.

Products and services

  • Lifecare Veterinary: Continuous-monitoring glucose system for animals adapted from Sencell, delivering uninterrupted glucose readings and wireless data transfer to the owner's smart device
  • NanoBioSensors: Nano 3D-printed ultra-small devices that measure various performance indicators in live tissue, enabling high-resolution, real-time diagnostics and precise in situ monitoring
  • Sencell: Implantable miniaturized glucose sensor measuring osmotic pressure to produce real-time glucose readings, operating for a minimum of six months and transmitting data wirelessly to a smart device

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lifecare

Nova Biomedical Logo

Nova Biomedical

HQ: United States Website
  • Description: Provider of advanced technology blood testing analyzers and diagnostic products using electrochemical and optical measuring techniques, including critical care blood gas analyzers (Stat Profile Prime Plus, Stat Profile pHOx Ultra), BioProfile FLEX2 for automated cell culture testing, Nova Max Pro for creatinine/eGFR kidney screening, Nova Vet ketone/glucose meter, and Lactate Plus for lactate monitoring.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nova Biomedical company profile →
Intarcia Logo

Intarcia

HQ: United States Website
  • Description: Provider of long-term therapies for chronic diseases, offering the MEDICITM Drug Delivery System for twice-yearly subcutaneous osmotic implants, ITCA 650 (twice-yearly exenatide implant) for type 2 diabetes, and an Ionic Liquid Platform converting injectable biologics and peptides into oral therapies; pipeline includes i2o-105s (long-acting GLP-1 receptor agonist), i2o-107 (long-acting amylin), and i2o-110 (dual agonist) for type 2 diabetes, obesity, and NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intarcia company profile →
Osler Diagnostics Logo

Osler Diagnostics

HQ: United Kingdom Website
  • Description: Provider of portable, low-cost, quick, and easy-to-use lab-quality diagnostics, featuring the Osler Origin 'portable lab' for a wide range of tests across healthcare settings. Offers lab-in-your-hand technology with microfluidic sample preparation and electrochemical biosensing, HemaTap sample addition for simplified cartridges, and a comprehensive test menu.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Osler Diagnostics company profile →
JanOne Logo

JanOne

HQ: United States Website
  • Description: Provider of pharmaceutical drug candidates targeting severe pain conditions, including JAN101, a twice-daily slow-release oral sodium nitrite formulation for treatment and prevention of peripheral artery disease (PAD) and associated pain, and Jan123, a low-dose naltrexone candidate for complex regional pain syndrome delivered via a unique oral biphasic release tablet.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full JanOne company profile →
Serodus Logo

Serodus

HQ: Norway Website
  • Description: Provider of Scandinavian drug development focused on unmet needs in diabetes and diabetic comorbidities. In-licenses early-stage candidates and partners after Phase II proof of clinical effect. Pipeline includes SER150, an anti-inflammatory targeting diabetic kidney disease via thromboxane synthase inhibition and receptor blockade, and SER140, an IL-1β receptor antagonist for diabetic kidney disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Serodus company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lifecare

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lifecare

2.2 - Growth funds investing in similar companies to Lifecare

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lifecare

4.2 - Public trading comparable groups for Lifecare

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lifecare

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lifecare

What does Lifecare do?

Lifecare is a provider of miniaturized, implantable glucose sensors and nano biosensing solutions. Offerings include Sencell, a real-time glucose sensor measuring osmotic pressure, lasting at least six months and transmitting data wirelessly to smart devices; NanoBioSensors for high-resolution diagnostics in live tissue; and Lifecare Veterinary for continuous animal glucose monitoring.

Who are Lifecare's competitors?

Lifecare's competitors and similar companies include Nova Biomedical, Intarcia, Osler Diagnostics, JanOne, and Serodus.

Where is Lifecare headquartered?

Lifecare is headquartered in Norway.

How many employees does Lifecare have?

Lifecare has 1,000 employees 🔒.

When was Lifecare founded?

Lifecare was founded in 2010 🔒.

What sector and industry vertical is Lifecare in?

Lifecare is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lifecare

Who are the top strategic acquirers in Lifecare's sector and industry

Top strategic M&A buyers and acquirers in Lifecare's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lifecare?

Top strategic M&A buyers groups and sectors for Lifecare include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lifecare's sector and industry vertical

Which are the top PE firms investing in Lifecare's sector and industry vertical?

Top PE firms investing in Lifecare's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lifecare's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lifecare's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lifecare's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lifecare include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lifecare's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lifecare?

The key public trading comparables and valuation benchmarks for Lifecare include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lifecare for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lifecare with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lifecare's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lifecare with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lifecare's' sector and industry vertical?

Access recent funding rounds and capital raises in Lifecare's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lifecare